{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:28:44Z","timestamp":1789496924291,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11284-7","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:24:58Z","timestamp":1763983498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The integrin\u2013matrix-FAK\u2013EMT axis in Anoikis resistance: a critical network in tumor progression and therapy"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8145-452X","authenticated-orcid":false,"given":"Erkan","family":"Alabas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8871-8943","authenticated-orcid":false,"given":"Ahmet Ata","family":"Ozcimen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"10","key":"11284_CR1","doi-asserted-by":"publisher","first-page":"6935","DOI":"10.1007\/s11033-021-06666-6","volume":"48","author":"G Babaei","year":"2021","unstructured":"Babaei G, Raei N, Toofani milani A et al (2021) The emerging role of miR-200 family in metastasis: focus on EMT, CSCs, angiogenesis, and anoikis. Mol Biol Rep 48(10):6935\u20136947","journal-title":"Mol Biol Rep"},{"issue":"11","key":"11284_CR2","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1007\/s11033-021-06706-1","volume":"48","author":"G Babaei","year":"2021","unstructured":"Babaei G, Aliarab A, Asghari Vostakolaei M et al (2021) Crosslink between p53 and metastasis: focus on epithelial\u2013mesenchymal transition, cancer stem cell, angiogenesis, autophagy, and anoikis. Mol Biol Rep 48(11):7545\u20137557","journal-title":"Mol Biol Rep"},{"key":"11284_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10585-022-10172-9","volume":"39","author":"SU Khan","year":"2022","unstructured":"Khan SU, Fatima K, Malik F (2022) Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis. Clin Exp Metas 39:715\u2013726","journal-title":"Clin Exp Metas"},{"key":"11284_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108522","volume":"250","author":"SU Khan","year":"2023","unstructured":"Khan SU, Fatima K, Malik F et al (2023) Cancer metastasis: molecular mechanisms and clinical perspectives. Pharmacol Ther 250:108522","journal-title":"Pharmacol Ther"},{"key":"11284_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01302-1","volume":"22","author":"SU Khan","year":"2024","unstructured":"Khan SU, Fatima K, Aisha S et al (2024) Unveiling the mechanisms and challenges of cancer drug resistance. Cell Commun Signal 22:109","journal-title":"Cell Commun Signal"},{"issue":"12","key":"11284_CR6","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli P, Giannoni E, Chiarugi P (2013) Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta Mol Cell Res 1833(12):3481\u20133498","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"4","key":"11284_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124(4):619\u2013626","journal-title":"J Cell Biol"},{"issue":"2","key":"11284_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jss.2009.07.011","volume":"164","author":"JM Coates","year":"2010","unstructured":"Coates JM, Galante JM, Bold RJ (2010) Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death. J Surg Res 164(2):301\u2013308","journal-title":"J Surg Res"},{"issue":"2","key":"11284_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P (2012) Anoikis: an emerging hallmark in health and diseases. J Pathol 226(2):380\u2013393","journal-title":"J Pathol"},{"key":"11284_CR10","doi-asserted-by":"crossref","unstructured":"Malagobadan S, Nagoor NH (2015) Evaluation of MicroRNAs regulating Anoikis pathways and its therapeutic potential. Biomed Res Int 2015(1): 1\u201310","DOI":"10.1155\/2015\/716816"},{"issue":"3","key":"11284_CR11","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/jcb.26363","volume":"119","author":"E Kakavandi","year":"2018","unstructured":"Kakavandi E, Shahbahrami R, Goudarzi H et al (2018) Anoikis resistance and oncoviruses. J Cell Biochem 119(3):2484\u201391","journal-title":"J Cell Biochem"},{"issue":"1","key":"11284_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-0983-5","volume":"18","author":"B Peltanova","year":"2019","unstructured":"Peltanova B, Raudenska M, Masarik M (2019) Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer 18(1):1\u201324","journal-title":"Mol Cancer"},{"issue":"2","key":"11284_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cellsig.2011.10.005","volume":"24","author":"X Zhong","year":"2012","unstructured":"Zhong X, Rescorla FJ (2012) Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal 24(2):393\u2013401","journal-title":"Cell Signal"},{"issue":"20","key":"11284_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21207624","volume":"21","author":"I Kaszak","year":"2020","unstructured":"Kaszak I, Witkowska-Pi\u0142aszewicz O, Niewiadomska Z et al (2020) Role of cadherins in cancer\u2014a review. Int J Mol Sci 21(20):1\u201317","journal-title":"Int J Mol Sci"},{"key":"11284_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/738137","volume":"2011","author":"PH Vachon","year":"2011","unstructured":"Vachon PH (2011) Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation. J Signal Transduct 2011:1\u201318","journal-title":"J Signal Transduct"},{"issue":"2","key":"11284_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.21873\/anticanres.13146","volume":"39","author":"N Aksorn","year":"2019","unstructured":"Aksorn N, Chanvorachote P (2019) Integrin as a molecular target for anti-cancer approaches in lung cancer. Anticancer Res 39(2):541\u2013548","journal-title":"Anticancer Res"},{"issue":"2","key":"11284_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.mam.2010.02.001","volume":"31","author":"S Sakamoto","year":"2010","unstructured":"Sakamoto S, Kyprianou N (2010) Targeting anoikis resistance in prostate cancer metastasis. Mol Aspects Med 31(2):205\u2013214","journal-title":"Mol Aspects Med"},{"issue":"3","key":"11284_CR18","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.2353\/ajpath.2010.091270","volume":"177","author":"C Horbinski","year":"2010","unstructured":"Horbinski C, Mojesky C, Kyprianou N (2010) Live free or die: tales of homeless (cells) in cancer. Am J Pathol 177(3):1044\u20131052","journal-title":"Am J Pathol"},{"issue":"10","key":"11284_CR19","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/cas.13336","volume":"108","author":"N Maishi","year":"2017","unstructured":"Maishi N, Hida K (2017) Tumor endothelial cells accelerate tumor metastasis. Cancer Sci 108(10):1921\u20131926","journal-title":"Cancer Sci"},{"key":"11284_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18010189","author":"R Ata","year":"2017","unstructured":"Ata R, Antonescu CN (2017) Integrins and cell metabolism: an intimate relationship impacting cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18010189","journal-title":"Int J Mol Sci"},{"key":"11284_CR21","doi-asserted-by":"crossref","unstructured":"Mei J, Jiang X-Y, Tian H-X et al (2024) Anoikis in cell fate, physiopathology, and therapeutic interventions. MedComm. 2024(5):1\u201332","DOI":"10.1002\/mco2.718"},{"issue":"5","key":"11284_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/15384101.2015.1130576","volume":"15","author":"J Alanko","year":"2016","unstructured":"Alanko J, Ivaska J (2016) Integrin endoadhesome signaling suppresses anoikis. Cell Cycle 15(5):605\u2013606","journal-title":"Cell Cycle"},{"issue":"5","key":"11284_CR23","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s11010-022-04384-6","volume":"477","author":"T Shi","year":"2022","unstructured":"Shi T, Zhang C, Xia S (2022) The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance. Mol Cell Biochem 477(5):1371\u20131380","journal-title":"Mol Cell Biochem"},{"issue":"3\u20134","key":"11284_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1615\/CritRevOncog.2016016955","volume":"21","author":"Z Cao","year":"2016","unstructured":"Cao Z, Livas T, Kyprianou N (2016) Anoikis and EMT: lethal liaisons during cancer progression. Crit Rev Oncog 21(3\u20134):155\u2013168","journal-title":"Crit Rev Oncog"},{"key":"11284_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pharmthera.2014.10.001","volume":"146","author":"BY Lee","year":"2015","unstructured":"Lee BY, Timpson P, Horvath LG et al (2015) FAK signaling in human cancer as a target for therapeutics. Pharmacol Ther 146:132\u201349","journal-title":"Pharmacol Ther"},{"issue":"2","key":"11284_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22020627","volume":"22","author":"HY Lee","year":"2021","unstructured":"Lee HY, Son SW, Moeng S et al (2021) The role of noncoding RNAs in the regulation of Anoikis and anchorage-independent growth in cancer. Int J Mol Sci 22(2):1\u201334","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11284_CR27","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/cancers3021639","volume":"3","author":"AR Safa","year":"2011","unstructured":"Safa AR, Pollok KE (2011) Targeting the anti-apoptotic protein c-FLIP for cancer therapy. Cancers 3(2):1639\u20131671","journal-title":"Cancers"},{"issue":"2","key":"11284_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.029","volume":"272","author":"CD Simpson","year":"2008","unstructured":"Simpson CD, Anyiwe K, Schimmer AD (2008) Anoikis resistance and tumor metastasis. Cancer Lett 272(2):177\u2013185","journal-title":"Cancer Lett"},{"issue":"17","key":"11284_CR29","doi-asserted-by":"publisher","first-page":"8307","DOI":"10.1158\/0008-5472.CAN-07-1687","volume":"67","author":"IA Mawji","year":"2007","unstructured":"Mawji IA, Simpson CD, Gronda M et al (2007) A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis. Cancer Res 67(17):8307\u201315","journal-title":"Cancer Res"},{"key":"11284_CR30","doi-asserted-by":"crossref","unstructured":"Kim YN, Koo KH, Sung JY et al (2012) Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol 2012(1):1\u201311","DOI":"10.1155\/2012\/306879"},{"issue":"4","key":"11284_CR31","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1590\/1519-6984.228437","volume":"81","author":"E Obeng","year":"2021","unstructured":"Obeng E (2021) Apoptosis (programmed cell death) and its signals-a review. Braz J Biol 81(4):1133\u20131143","journal-title":"Braz J Biol"},{"issue":"5","key":"11284_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/2159-8290.CD-15-0011","volume":"5","author":"AN Hata","year":"2015","unstructured":"Hata AN, Engelman JA, Faber AC (2015) The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov 5(5):475\u2013487","journal-title":"Cancer Discov"},{"issue":"1","key":"11284_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1242\/jcs.120907","volume":"126","author":"SM Frisch","year":"2013","unstructured":"Frisch SM, Schaller M, Cieply B (2013) Mechanisms that link the oncogenic epithelial- mesenchymal transition to suppression of anoikis. J Cell Sci 126(1):21\u201329","journal-title":"J Cell Sci"},{"key":"11284_CR34","doi-asserted-by":"publisher","first-page":"217750","DOI":"10.1016\/j.canlet.2025.217750","volume":"624","author":"P Shaw","year":"2025","unstructured":"Shaw P, Bhowmik AD, Pillai MSG et al (2025) Anoikis resistance in cancer: mechanisms, therapeutic strategies, potential targets, and models for enhanced understanding. Cancer Lett 624:217750\u201385","journal-title":"Cancer Lett"},{"issue":"5","key":"11284_CR35","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS (2021) Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol 18(5):1106\u20131121","journal-title":"Cell Mol Immunol"},{"issue":"March","key":"11284_CR36","first-page":"1","volume":"11","author":"FO Adeshakin","year":"2021","unstructured":"Adeshakin FO, Adeshakin AO, Afolabi LO et al (2021) Mechanisms for modulating Anoikis resistance in cancer and the relevance of metabolic reprogramming. Front Oncol 11(March):1\u201321","journal-title":"Front Oncol"},{"issue":"3","key":"11284_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh R, Letai A, Sarosiek K (2019) Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol 20(3):175\u2013193","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"30","key":"11284_CR38","doi-asserted-by":"publisher","first-page":"26533","DOI":"10.1074\/jbc.M111.265322","volume":"286","author":"M Hausmann","year":"2011","unstructured":"Hausmann M, Leucht K, Ploner C et al (2011) BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells. J Biol Chem 286(30):26533\u201340","journal-title":"J Biol Chem"},{"issue":"11","key":"11284_CR39","doi-asserted-by":"publisher","first-page":"19471","DOI":"10.1002\/jcp.28740","volume":"234","author":"M Ashrafizadeh","year":"2019","unstructured":"Ashrafizadeh M, Mohammadinejad R, Tavakol S et al (2019) Autophagy, anoikis, ferroptosis, necroptosis, and endoplasmic reticulum stress: potential applications in melanoma therapy. J Cell Physiol 234(11):19471\u20139","journal-title":"J Cell Physiol"},{"issue":"1","key":"11284_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-023-01247-5","volume":"21","author":"YH Han","year":"2023","unstructured":"Han YH, Wang Y, Lee SJ, Jin MH, Sun HN, Kwon T (2023) Regulation of anoikis by extrinsic death receptor pathways. Cell Commun Signal 21(1):1\u201314","journal-title":"Cell Commun Signal"},{"key":"11284_CR41","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s11010-024-05199-3","volume":"480","author":"C He","year":"2025","unstructured":"He C, He J (2025) Metabolic reprogramming and signaling adaptations in anoikis resistance: mechanisms and therapeutic targets. Mol Cell Biochem 480:3315\u20133342","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"11284_CR42","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) Review series the basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420\u20131428","journal-title":"J Clin Invest"},{"issue":"1","key":"11284_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2025.2484159","volume":"11","author":"J Jiang","year":"2025","unstructured":"Jiang J, Peng W, Sun N et al (2025) Unraveling the anoikis-cancer nexus: a bibliometric analysis of research trends and mechanisms. Future Sci OA 11(1):2484159","journal-title":"Future Sci OA"},{"issue":"2","key":"11284_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbcan.2009.03.002","volume":"1796","author":"A Voulgari","year":"2009","unstructured":"Voulgari A, Pintzas A (2009) Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta Rev Cancer 1796(2):75\u201390","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"4","key":"11284_CR45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/iju.13505","volume":"25","author":"D Begemann","year":"2018","unstructured":"Begemann D, Anastos H, Kyprianou N (2018) Cell death under epithelial\u2013mesenchymal transition control in prostate cancer therapeutic response. Int J Urol 25(4):318\u2013326","journal-title":"Int J Urol"},{"issue":"6","key":"11284_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Tamma R, Annese T (2020) Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol 13(6):100773","journal-title":"Transl Oncol"},{"issue":"19","key":"11284_CR47","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1242\/jcs.072165","volume":"124","author":"MC Guadamillas","year":"2011","unstructured":"Guadamillas MC, Cerezo A, del Pozo MA (2011) Overcoming anoikis - pathways to anchorage independent growth in cancer. J Cell Sci 124(19):3189\u201397","journal-title":"J Cell Sci"},{"issue":"13","key":"11284_CR48","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1128\/MCB.01164-08","volume":"29","author":"MA Smit","year":"2009","unstructured":"Smit MA, Geiger TR, Song J-Y et al (2009) A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 29(13):3722\u201337","journal-title":"Mol Cell Biol"},{"issue":"2","key":"11284_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/0008-5472.CAN-07-5682","volume":"68","author":"S Spaderna","year":"2008","unstructured":"Spaderna S, Schmalhofer O, Wahlbuhl M et al (2008) The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68(2):537\u201344","journal-title":"Cancer Res"},{"issue":"2","key":"11284_CR50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.canlet.2010.04.008","volume":"296","author":"Y Takeyama","year":"2010","unstructured":"Takeyama Y, Sato M, Horio M et al (2010) Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Lett 296(2):216\u201324","journal-title":"Cancer Lett"},{"issue":"35","key":"11284_CR51","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1038\/onc.2011.96","volume":"30","author":"MA Smit","year":"2011","unstructured":"Smit MA, Peeper DS (2011) Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis. Oncogene 30(35):3735\u20133744","journal-title":"Oncogene"},{"issue":"13","key":"11284_CR52","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1242\/jcs.021782","volume":"121","author":"ME Diamond","year":"2008","unstructured":"Diamond ME, Sun L, Ottaviano AJ et al (2008) Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium. J Cell Sci 121(13):2197\u2013207","journal-title":"J Cell Sci"},{"key":"11284_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01259-6","author":"X Pang","year":"2023","unstructured":"Pang X, He X, Qiu Z et al (2023) Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-022-01259-6","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"11284_CR54","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/apm.13041","volume":"128","author":"M Patankar","year":"2020","unstructured":"Patankar M, Mattila T, V\u00e4yrynen JP et al (2020) Putative anoikis-resistant subpopulations in colorectal carcinoma: a marker of adverse prognosis. APMIS 128(5):390\u2013400","journal-title":"APMIS"},{"key":"11284_CR55","unstructured":"Chen YC, Ingram P, Lou X, Yoon E (2012) Single cell suspension culture using polyhema coating for anoikis assay and sphere formation. Proc 16th Int Conf Miniaturized Syst Chem Life Sci MicroTAS 2012. pp.106\u20138. Okinawa, Japan. Chemical and Biological Microsystems Society"},{"issue":"7","key":"11284_CR56","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41416-020-0970-z","volume":"123","author":"C-fen Mo","year":"2020","unstructured":"Mo C-fen, Li J, Yang S-xia et al (2020) IQGAP1 promotes anoikis resistance and metastasis through Rac1-dependent ROS accumulation and activation of Src\/FAK signalling in hepatocellular carcinoma. Br J Cancer 123(7):1154\u201363","journal-title":"Br J Cancer"},{"issue":"4","key":"11284_CR57","first-page":"720","volume":"30","author":"CF Labuschagne","year":"2019","unstructured":"Labuschagne CF, Cheung EC, Blagih J et al (2019) Cell clustering promotes a metabolic switch that supports metastatic colonization. Cell 30(4):720\u2013734","journal-title":"Cell"},{"issue":"12","key":"11284_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells8121620","volume":"8","author":"NE Ryu","year":"2019","unstructured":"Ryu NE, Lee SH, Park H (2019) Spheroid culture system methods and applications for mesenchymal stem cells. Cells 8(12):1\u201313","journal-title":"Cells"},{"issue":"1","key":"11284_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-73680-6","volume":"14","author":"I Fl\u00f6rkemeier","year":"2024","unstructured":"Fl\u00f6rkemeier I, Antons LK, Weimer JP et al (2024) Multicellular ovarian cancer spheroids: novel 3D model to mimic tumour complexity. Sci Rep 14(1):1\u201318","journal-title":"Sci Rep"},{"key":"11284_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jcis.2016.07.075","volume":"482","author":"L Casarrubios","year":"2016","unstructured":"Casarrubios L, Matesanz MC, S\u00e1nchez-Salcedo S (2016) Nanocrystallinity effects on osteoblast and osteoclast response to silicon substituted hydroxyapatite. J Colloid Interface Sci 482:112\u2013120","journal-title":"J Colloid Interface Sci"},{"issue":"4","key":"11284_CR61","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s12253-020-00837-9","volume":"26","author":"V Koroknai","year":"2020","unstructured":"Koroknai V, Patel V, Sz\u00e1sz I et al (2020) Gene expression signature of BRAF inhibitor resistant melanoma spheroids. Pathol Oncol Res 26(4):2557\u201366","journal-title":"Pathol Oncol Res"},{"issue":"July","key":"11284_CR62","doi-asserted-by":"publisher","first-page":"100777","DOI":"10.1016\/j.drup.2021.100777","volume":"58","author":"Z Su","year":"2021","unstructured":"Su Z, Dong S, Zhao SC et al (2021) Novel nanomedicines to overcome cancer multidrug resistance. Drug Resist Updat 58(July):100777","journal-title":"Drug Resist Updat"},{"key":"11284_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101099","volume":"75","author":"Y Wang","year":"2024","unstructured":"Wang Y, Cheng S, Fleishman JS et al (2024) Targeting anoikis resistance as a strategy for cancer therapy. Drug Resist Updat 75:101099","journal-title":"Drug Resist Updat"},{"issue":"1","key":"11284_CR64","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.canlet.2013.01.021","volume":"332","author":"H Lee","year":"2013","unstructured":"Lee H, Park S, Kim J Bin et al (2013) Entrapped doxorubicin nanoparticles for the treatment of metastatic anoikis-resistant cancer cells. Cancer Lett 332(1):110\u20139","journal-title":"Cancer Lett"},{"issue":"15","key":"11284_CR65","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.7150\/thno.25131","volume":"8","author":"H Lee","year":"2018","unstructured":"Lee H, Jang Y, Park S et al (2018) Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer. Theranostics 8(15):4247\u20134261","journal-title":"Theranostics"},{"key":"11284_CR66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.critrevonc.2019.05.009","volume":"140","author":"A Tajbakhsh","year":"2019","unstructured":"Tajbakhsh A, Rivandi M, Abedini S et al (2019) Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): a review. Crit Rev Oncol Hematol 140:17\u201327","journal-title":"Crit Rev Oncol Hematol"},{"key":"11284_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202203518","author":"L Wang","year":"2022","unstructured":"Wang L, Li C, Wang J et al (2022) Transformable ECM deprivation system effectively suppresses renal cell carcinoma by reversing anoikis resistance and increasing chemotherapy sensitivity. Adv Mater. https:\/\/doi.org\/10.1002\/adma.202203518","journal-title":"Adv Mater"},{"issue":"10","key":"11284_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2014.421","volume":"5","author":"Q Zhao","year":"2014","unstructured":"Zhao Q, Piyush T, Chen C et al (2014) MUC1 extracellular domain confers resistance of epithelial cancer cells to Anoikis. Cell Death Dis 5(10):1\u201310","journal-title":"Cell Death Dis"},{"key":"11284_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05858-5","author":"X Wang","year":"2024","unstructured":"Wang X, Gao L, Li H et al (2024) Integrative analysis of multi-omics data identified PLG as key gene related to anoikis resistance and immune phenotypes in hepatocellular carcinoma. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-024-05858-5","journal-title":"J Transl Med"},{"issue":"14","key":"11284_CR70","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.7150\/ijms.60610","volume":"18","author":"S Xia","year":"2021","unstructured":"Xia S, Wu J, Zhou W et al (2021) Hrc promotes anoikis resistance and metastasis by suppressing endoplasmic reticulum stress in hepatocellular carcinoma. Int J Med Sci 18(14):3112\u201324","journal-title":"Int J Med Sci"},{"issue":"38","key":"11284_CR71","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/s41388-021-01988-y","volume":"40","author":"S Du","year":"2021","unstructured":"Du S, Yang Z, Lu X et al (2021) Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C\/EBP\u03b2-mediated PDGFB autocrine and paracrine signaling. Oncogene 40(38):5764\u20135779","journal-title":"Oncogene"},{"key":"11284_CR72","doi-asserted-by":"crossref","unstructured":"Reavis HD, Gysler SM, McKenney GB et al (2024) Norepinephrine induces Anoikis resistance in high-grade serous ovarian cancer precursor cells. JCI Insight 9(5)","DOI":"10.1172\/jci.insight.170961"},{"issue":"1","key":"11284_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-015-0466-4","volume":"13","author":"JM Foley","year":"2015","unstructured":"Foley JM, Scholten DJ, Monks NR et al (2015) Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling. J Transl Med 13(1):1\u201312","journal-title":"J Transl Med"},{"key":"11284_CR74","doi-asserted-by":"crossref","unstructured":"Lu Q, Wang L, Gao Y et al (2021) LncRNA APOC1P1\u20133 promoting anoikis\u2013resistance of breast cancer cells. Cancer Cell Int 1\u201313","DOI":"10.1186\/s12935-021-01916-w"},{"key":"11284_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00643-0","author":"YC Wen","year":"2024","unstructured":"Wen YC, Lin YW, Ho KH et al (2024) The oncogenic ADAMTS1\u2013VCAN\u2013EGFR cyclic axis drives anoikis resistance and invasion in renal cell carcinoma. Cell Mol Biol Lett. https:\/\/doi.org\/10.1186\/s11658-024-00643-0","journal-title":"Cell Mol Biol Lett"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11284-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11284-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11284-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:14:06Z","timestamp":1764180846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11284-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11284"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11284-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"108"}}